JAMES WALTON: Open Payments
NPI 1578724779 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 50 payments from 13 companies in 2025. Trend: 2023 $945 · 2024 $1,043 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $253 |
| ABBVIE INC. | 15 | $218 |
| W. L. Gore & Associates, Inc. | 1 | $125 |
| PFIZER INC. | 3 | $69 |
| Abbott Laboratories | 3 | $52 |
| Dexcom, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
Products named: Ozempic, GORE PROPATEN Vascular Graft, UBRELVY, VRAYLAR, FREESTYLE LIBRE 3, Wegovy, ELIQUIS, QULIPTA.
Industry payments across GA — which companies pay providers there.
